Two Sigma Advisers LP Buys 501,900 Shares of Keurig Dr Pepper Inc. (NASDAQ:KDP)

Two Sigma Advisers LP increased its holdings in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 20.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,001,800 shares of the company's stock after purchasing an additional 501,900 shares during the quarter. Two Sigma Advisers LP owned 0.22% of Keurig Dr Pepper worth $96,418,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in KDP. Vanguard Group Inc. raised its position in Keurig Dr Pepper by 23.6% in the 4th quarter. Vanguard Group Inc. now owns 119,587,162 shares of the company's stock worth $3,841,140,000 after purchasing an additional 22,856,757 shares during the period. Price T Rowe Associates Inc. MD raised its position in Keurig Dr Pepper by 36.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company's stock worth $1,755,564,000 after purchasing an additional 14,473,054 shares during the period. Barrow Hanley Mewhinney & Strauss LLC raised its position in Keurig Dr Pepper by 65.0% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 21,219,771 shares of the company's stock worth $681,579,000 after purchasing an additional 8,363,192 shares during the period. Norges Bank purchased a new position in Keurig Dr Pepper in the 4th quarter worth $197,819,000. Finally, Wellington Management Group LLP raised its position in Keurig Dr Pepper by 10.3% in the 4th quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company's stock worth $1,946,561,000 after purchasing an additional 5,646,179 shares during the period. Hedge funds and other institutional investors own 93.99% of the company's stock.

Insider Activity at Keurig Dr Pepper

In related news, major shareholder Bevco B.V. Jab sold 83,950,000 shares of the business's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $32.65, for a total transaction of $2,740,967,500.00. Following the transaction, the insider now owns 134,113,479 shares in the company, valued at $4,378,805,089.35. The trade was a 38.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Angela A. Stephens sold 7,350 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $34.17, for a total transaction of $251,149.50. Following the transaction, the vice president now owns 74,587 shares in the company, valued at $2,548,637.79. This represents a 8.97% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 84,863,850 shares of company stock worth $2,772,203,450 over the last 90 days. 0.40% of the stock is owned by company insiders.

Keurig Dr Pepper Price Performance

Shares of NASDAQ KDP opened at $33.82 on Monday. Keurig Dr Pepper Inc. has a 1 year low of $30.12 and a 1 year high of $38.28. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.53 and a quick ratio of 0.36. The company's 50-day moving average is $34.22 and its 200 day moving average is $33.01. The stock has a market capitalization of $45.93 billion, a P/E ratio of 20.50, a P/E/G ratio of 2.42 and a beta of 0.52.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.04. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The company had revenue of $3.64 billion for the quarter, compared to analysts' expectations of $3.57 billion. During the same quarter in the previous year, the company earned $0.38 earnings per share. Keurig Dr Pepper's quarterly revenue was up 4.8% on a year-over-year basis. On average, sell-side analysts expect that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on KDP shares. Barclays lifted their target price on shares of Keurig Dr Pepper from $37.00 to $38.00 and gave the stock an "overweight" rating in a research report on Monday, April 28th. Argus started coverage on shares of Keurig Dr Pepper in a research report on Wednesday, April 16th. They issued a "buy" rating and a $40.00 target price on the stock. Morgan Stanley upgraded shares of Keurig Dr Pepper from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $38.00 to $40.00 in a research report on Tuesday, April 1st. UBS Group lifted their target price on shares of Keurig Dr Pepper from $40.00 to $42.00 and gave the stock a "buy" rating in a research report on Thursday, April 17th. Finally, HSBC upgraded shares of Keurig Dr Pepper from a "hold" rating to a "buy" rating and boosted their price objective for the company from $36.00 to $42.00 in a research report on Friday, April 25th. Four investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Keurig Dr Pepper has an average rating of "Moderate Buy" and a consensus price target of $39.33.

Keurig Dr Pepper Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.